ZNF460 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68310000048244E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.33540000011057E-07 |
Normal-vs-Stage2 |
9.6116000000035E-05 |
Normal-vs-Stage3 |
1.11400000002426E-07 |
Normal-vs-Stage4 |
9.52459999759014E-08 |
Stage1-vs-Stage2 |
3.096400E-01 |
Stage1-vs-Stage3 |
2.510400E-01 |
Stage1-vs-Stage4 |
1.976580E-01 |
Stage2-vs-Stage3 |
1.167240E-01 |
Stage2-vs-Stage4 |
8.619900E-02 |
Stage3-vs-Stage4 |
8.332200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.70739999974623E-07 |
Normal-vs-AfricanAmerican |
7.40189998182927E-09 |
Normal-vs-Asian |
5.100600E-01 |
Caucasian-vs-AfricanAmerican |
2.172100E-02 |
Caucasian-vs-Asian |
3.984400E-02 |
AfricanAmerican-vs-Asian |
6.246000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.07910000011347E-08 |
Normal-vs-Female |
1.42640000000416E-06 |
Male-vs-Female |
1.221020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.03780000038078E-07 |
Normal-vs-Age(41-60Yrs) |
1.11800000002216E-06 |
Normal-vs-Age(61-80Yrs) |
1.0858999999197E-07 |
Normal-vs-Age(81-100Yrs) |
6.36920000000041E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.009800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.412600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.942000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.910550E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.685000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.953000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.983600E-03 |
Normal-vs-Grade 2 |
1.39359999995481E-06 |
Normal-vs-Grade 3 |
5.52769999773162E-08 |
Normal-vs-Grade 4 |
5.05010000484418E-08 |
Grade 1-vs-Grade 2 |
2.985400E-01 |
Grade 1-vs-Grade 3 |
9.519600E-02 |
Grade 1-vs-Grade 4 |
5.730100E-02 |
Grade 2-vs-Grade 3 |
6.426300E-02 |
Grade 2-vs-Grade 4 |
4.978500E-02 |
Grade 3-vs-Grade 4 |
5.469800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.56846000000099E-05 |
Normal-vs-ccB subtype |
2.82799999973271E-07 |
ccA subtype-vs-ccB subtype |
7.865900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.07169999999479E-06 |
Normal-vs-N1 |
3.86129994645046E-09 |
N0-vs-N1 |
1.340940E-03 |
|
|